カテゴリ： 世界, 医療/バイオ, QYResearch

ブルセラ症治療の世界市場2023年：経口式、注射式

■ 英語タイトル：Global Brucellosis Treatment Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA7434）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA7434
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：88
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ブルセラ症治療の世界市場2023年：経口式、注射式]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査資料はブルセラ症治療のグローバル市場について調査・分析し、世界のブルセラ症治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（経口式、注射式）、用途別セグメント分析（病院、薬局、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Pfizer Inc.、Bayer、Huvepharma、OraPharma,Inc.、Merck & Co.Inc.、RempexPharmaceuticals,Inc.、ZeotisInc.、BoehringerIngelheim International GmbH.、Elanco、Virabc Inc.などが含まれています。ブルセラ症治療のグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、ブルセラ症治療市場規模を算出する際に考慮しました。

・ブルセラ症治療市場の概要
- ブルセラ症治療の種類別セグメント
- 世界のブルセラ症治療市場規模：タイプ別分析（経口式、注射式）
- ブルセラ症治療の用途別セグメント
- 世界のブルセラ症治療市場規模：用途別分析（病院、薬局、その他）
- 世界のブルセラ症治療市場規模予測（2018年-2029年）

・ブルセラ症治療市場の成長トレンド
- ブルセラ症治療の地域別市場規模（2018年-2029年）
- ブルセラ症治療市場ダイナミクス
- ブルセラ症治療の業界動向
- ブルセラ症治療市場の成長ドライバ、課題、阻害要因

・主要企業別競争状況
- 企業別市場シェア
- 世界の主要企業、業界ランキング分析
- 市場への参入、M＆A動向

・種類別セグメント：経口式、注射式
- 世界のブルセラ症治療のタイプ別市場規模（2018年-2023年）
- 世界のブルセラ症治療のタイプ別市場規模（2024年-2029年）

・用途別セグメント：病院、薬局、その他
- 世界のブルセラ症治療の用途別市場規模（2018年-2023年）
- 世界のブルセラ症治療の用途別市場規模（2024年-2029年）

・ブルセラ症治療の地域別市場規模
- 北米のブルセラ症治療市場規模（2018年-2029年）
- 米国のブルセラ症治療市場規模（2018年-2029年）
- ヨーロッパのブルセラ症治療市場規模（2018年-2029年）
- アジア太平洋のブルセラ症治療市場規模（2018年-2029年）
- 中国のブルセラ症治療市場規模（2018年-2029年）
- 日本のブルセラ症治療市場規模（2018年-2029年）
- 韓国のブルセラ症治療市場規模（2018年-2029年）
- インドのブルセラ症治療市場規模（2018年-2029年）
- オーストラリアのブルセラ症治療市場規模（2018年-2029年）
- 中南米のブルセラ症治療市場規模（2018年-2029年）
- 中東・アフリカのブルセラ症治療市場規模（2018年-2029年）

・主要企業のプロファイル：企業情報、事業概要、売上、動向
Pfizer Inc.、Bayer、Huvepharma、OraPharma,Inc.、Merck & Co.Inc.、RempexPharmaceuticals,Inc.、ZeotisInc.、BoehringerIngelheim International GmbH.、Elanco、Virabc Inc.

・アナリストの観点/結論

・調査手法と情報源

Highlights
The global Brucellosis Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Brucellosis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Brucellosis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Brucellosis Treatment in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Brucellosis Treatment include Pfizer Inc., Bayer, Huvepharma, OraPharma,Inc., Merck & Co.Inc., RempexPharmaceuticals,Inc., ZeotisInc., BoehringerIngelheim International GmbH. and Elanco, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Brucellosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brucellosis Treatment.
The Brucellosis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Brucellosis Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Brucellosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Pfizer Inc.
Bayer
Huvepharma
OraPharma,Inc.
Merck & Co.Inc.
RempexPharmaceuticals,Inc.
ZeotisInc.
BoehringerIngelheim International GmbH.
Elanco
Virabc Inc.
Segment by Type
Oral
Injection
Segment by Application
Hospital
Pharmacy
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brucellosis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Brucellosis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Brucellosis Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Brucellosis Treatment Market Perspective (2018-2029)
2.2 Brucellosis Treatment Growth Trends by Region
2.2.1 Global Brucellosis Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Brucellosis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Brucellosis Treatment Forecasted Market Size by Region (2024-2029)
2.3 Brucellosis Treatment Market Dynamics
2.3.1 Brucellosis Treatment Industry Trends
2.3.2 Brucellosis Treatment Market Drivers
2.3.3 Brucellosis Treatment Market Challenges
2.3.4 Brucellosis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Brucellosis Treatment Players by Revenue
3.1.1 Global Top Brucellosis Treatment Players by Revenue (2018-2023)
3.1.2 Global Brucellosis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Brucellosis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Brucellosis Treatment Revenue
3.4 Global Brucellosis Treatment Market Concentration Ratio
3.4.1 Global Brucellosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Brucellosis Treatment Revenue in 2022
3.5 Brucellosis Treatment Key Players Head office and Area Served
3.6 Key Players Brucellosis Treatment Product Solution and Service
3.7 Date of Enter into Brucellosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Brucellosis Treatment Breakdown Data by Type
4.1 Global Brucellosis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Brucellosis Treatment Forecasted Market Size by Type (2024-2029)
5 Brucellosis Treatment Breakdown Data by Application
5.1 Global Brucellosis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Brucellosis Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Brucellosis Treatment Market Size (2018-2029)
6.2 North America Brucellosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Brucellosis Treatment Market Size by Country (2018-2023)
6.4 North America Brucellosis Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Brucellosis Treatment Market Size (2018-2029)
7.2 Europe Brucellosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Brucellosis Treatment Market Size by Country (2018-2023)
7.4 Europe Brucellosis Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Brucellosis Treatment Market Size (2018-2029)
8.2 Asia-Pacific Brucellosis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Brucellosis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Brucellosis Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Brucellosis Treatment Market Size (2018-2029)
9.2 Latin America Brucellosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Brucellosis Treatment Market Size by Country (2018-2023)
9.4 Latin America Brucellosis Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Brucellosis Treatment Market Size (2018-2029)
10.2 Middle East & Africa Brucellosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Brucellosis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Brucellosis Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Detail
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Brucellosis Treatment Introduction
11.1.4 Pfizer Inc. Revenue in Brucellosis Treatment Business (2018-2023)
11.1.5 Pfizer Inc. Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Brucellosis Treatment Introduction
11.2.4 Bayer Revenue in Brucellosis Treatment Business (2018-2023)
11.2.5 Bayer Recent Development
11.3 Huvepharma
11.3.1 Huvepharma Company Detail
11.3.2 Huvepharma Business Overview
11.3.3 Huvepharma Brucellosis Treatment Introduction
11.3.4 Huvepharma Revenue in Brucellosis Treatment Business (2018-2023)
11.3.5 Huvepharma Recent Development
11.4 OraPharma,Inc.
11.4.1 OraPharma,Inc. Company Detail
11.4.2 OraPharma,Inc. Business Overview
11.4.3 OraPharma,Inc. Brucellosis Treatment Introduction
11.4.4 OraPharma,Inc. Revenue in Brucellosis Treatment Business (2018-2023)
11.4.5 OraPharma,Inc. Recent Development
11.5 Merck & Co.Inc.
11.5.1 Merck & Co.Inc. Company Detail
11.5.2 Merck & Co.Inc. Business Overview
11.5.3 Merck & Co.Inc. Brucellosis Treatment Introduction
11.5.4 Merck & Co.Inc. Revenue in Brucellosis Treatment Business (2018-2023)
11.5.5 Merck & Co.Inc. Recent Development
11.6 RempexPharmaceuticals,Inc.
11.6.1 RempexPharmaceuticals,Inc. Company Detail
11.6.2 RempexPharmaceuticals,Inc. Business Overview
11.6.3 RempexPharmaceuticals,Inc. Brucellosis Treatment Introduction
11.6.4 RempexPharmaceuticals,Inc. Revenue in Brucellosis Treatment Business (2018-2023)
11.6.5 RempexPharmaceuticals,Inc. Recent Development
11.7 ZeotisInc.
11.7.1 ZeotisInc. Company Detail
11.7.2 ZeotisInc. Business Overview
11.7.3 ZeotisInc. Brucellosis Treatment Introduction
11.7.4 ZeotisInc. Revenue in Brucellosis Treatment Business (2018-2023)
11.7.5 ZeotisInc. Recent Development
11.8 BoehringerIngelheim International GmbH.
11.8.1 BoehringerIngelheim International GmbH. Company Detail
11.8.2 BoehringerIngelheim International GmbH. Business Overview
11.8.3 BoehringerIngelheim International GmbH. Brucellosis Treatment Introduction
11.8.4 BoehringerIngelheim International GmbH. Revenue in Brucellosis Treatment Business (2018-2023)
11.8.5 BoehringerIngelheim International GmbH. Recent Development
11.9 Elanco
11.9.1 Elanco Company Detail
11.9.2 Elanco Business Overview
11.9.3 Elanco Brucellosis Treatment Introduction
11.9.4 Elanco Revenue in Brucellosis Treatment Business (2018-2023)
11.9.5 Elanco Recent Development
11.10 Virabc Inc.
11.10.1 Virabc Inc. Company Detail
11.10.2 Virabc Inc. Business Overview
11.10.3 Virabc Inc. Brucellosis Treatment Introduction
11.10.4 Virabc Inc. Revenue in Brucellosis Treatment Business (2018-2023)
11.10.5 Virabc Inc. Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Brucellosis Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Brucellosis Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Brucellosis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Brucellosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Brucellosis Treatment Market Share by Region (2018-2023)
Table 8. Global Brucellosis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Brucellosis Treatment Market Share by Region (2024-2029)
Table 10. Brucellosis Treatment Market Trends
Table 11. Brucellosis Treatment Market Drivers
Table 12. Brucellosis Treatment Market Challenges
Table 13. Brucellosis Treatment Market Restraints
Table 14. Global Brucellosis Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Brucellosis Treatment Market Share by Players (2018-2023)
Table 16. Global Top Brucellosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucellosis Treatment as of 2022)
Table 17. Ranking of Global Top Brucellosis Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Brucellosis Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Brucellosis Treatment Product Solution and Service
Table 21. Date of Enter into Brucellosis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Brucellosis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Brucellosis Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Brucellosis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Brucellosis Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global Brucellosis Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Brucellosis Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Brucellosis Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Brucellosis Treatment Revenue Market Share by Application (2024-2029)
Table 31. North America Brucellosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Brucellosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Brucellosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Brucellosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Brucellosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Brucellosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Brucellosis Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Brucellosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Brucellosis Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Brucellosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Brucellosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Brucellosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Brucellosis Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Brucellosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Brucellosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. Pfizer Inc. Company Detail
Table 47. Pfizer Inc. Business Overview
Table 48. Pfizer Inc. Brucellosis Treatment Product
Table 49. Pfizer Inc. Revenue in Brucellosis Treatment Business (2018-2023) & (US$ Million)
Table 50. Pfizer Inc. Recent Development
Table 51. Bayer Company Detail
Table 52. Bayer Business Overview
Table 53. Bayer Brucellosis Treatment Product
Table 54. Bayer Revenue in Brucellosis Treatment Business (2018-2023) & (US$ Million)
Table 55. Bayer Recent Development
Table 56. Huvepharma Company Detail
Table 57. Huvepharma Business Overview
Table 58. Huvepharma Brucellosis Treatment Product
Table 59. Huvepharma Revenue in Brucellosis Treatment Business (2018-2023) & (US$ Million)
Table 60. Huvepharma Recent Development
Table 61. OraPharma,Inc. Company Detail
Table 62. OraPharma,Inc. Business Overview
Table 63. OraPharma,Inc. Brucellosis Treatment Product
Table 64. OraPharma,Inc. Revenue in Brucellosis Treatment Business (2018-2023) & (US$ Million)
Table 65. OraPharma,Inc. Recent Development
Table 66. Merck & Co.Inc. Company Detail
Table 67. Merck & Co.Inc. Business Overview
Table 68. Merck & Co.Inc. Brucellosis Treatment Product
Table 69. Merck & Co.Inc. Revenue in Brucellosis Treatment Business (2018-2023) & (US$ Million)
Table 70. Merck & Co.Inc. Recent Development
Table 71. RempexPharmaceuticals,Inc. Company Detail
Table 72. RempexPharmaceuticals,Inc. Business Overview
Table 73. RempexPharmaceuticals,Inc. Brucellosis Treatment Product
Table 74. RempexPharmaceuticals,Inc. Revenue in Brucellosis Treatment Business (2018-2023) & (US$ Million)
Table 75. RempexPharmaceuticals,Inc. Recent Development
Table 76. ZeotisInc. Company Detail
Table 77. ZeotisInc. Business Overview
Table 78. ZeotisInc. Brucellosis Treatment Product
Table 79. ZeotisInc. Revenue in Brucellosis Treatment Business (2018-2023) & (US$ Million)
Table 80. ZeotisInc. Recent Development
Table 81. BoehringerIngelheim International GmbH. Company Detail
Table 82. BoehringerIngelheim International GmbH. Business Overview
Table 83. BoehringerIngelheim International GmbH. Brucellosis Treatment Product
Table 84. BoehringerIngelheim International GmbH. Revenue in Brucellosis Treatment Business (2018-2023) & (US$ Million)
Table 85. BoehringerIngelheim International GmbH. Recent Development
Table 86. Elanco Company Detail
Table 87. Elanco Business Overview
Table 88. Elanco Brucellosis Treatment Product
Table 89. Elanco Revenue in Brucellosis Treatment Business (2018-2023) & (US$ Million)
Table 90. Elanco Recent Development
Table 91. Virabc Inc. Company Detail
Table 92. Virabc Inc. Business Overview
Table 93. Virabc Inc. Brucellosis Treatment Product
Table 94. Virabc Inc. Revenue in Brucellosis Treatment Business (2018-2023) & (US$ Million)
Table 95. Virabc Inc. Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Brucellosis Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Brucellosis Treatment Market Share by Type: 2022 VS 2029
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. Global Brucellosis Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Brucellosis Treatment Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Pharmacy Case Studies
Figure 9. Others Case Studies
Figure 10. Brucellosis Treatment Report Years Considered
Figure 11. Global Brucellosis Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Brucellosis Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Brucellosis Treatment Market Share by Region: 2022 VS 2029
Figure 14. Global Brucellosis Treatment Market Share by Players in 2022
Figure 15. Global Top Brucellosis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucellosis Treatment as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Brucellosis Treatment Revenue in 2022
Figure 17. North America Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Brucellosis Treatment Market Share by Country (2018-2029)
Figure 19. United States Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Brucellosis Treatment Market Share by Country (2018-2029)
Figure 23. Germany Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Brucellosis Treatment Market Share by Region (2018-2029)
Figure 31. China Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Brucellosis Treatment Market Share by Country (2018-2029)
Figure 39. Mexico Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Brucellosis Treatment Market Share by Country (2018-2029)
Figure 43. Turkey Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Brucellosis Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Pfizer Inc. Revenue Growth Rate in Brucellosis Treatment Business (2018-2023)
Figure 46. Bayer Revenue Growth Rate in Brucellosis Treatment Business (2018-2023)
Figure 47. Huvepharma Revenue Growth Rate in Brucellosis Treatment Business (2018-2023)
Figure 48. OraPharma,Inc. Revenue Growth Rate in Brucellosis Treatment Business (2018-2023)
Figure 49. Merck & Co.Inc. Revenue Growth Rate in Brucellosis Treatment Business (2018-2023)
Figure 50. RempexPharmaceuticals,Inc. Revenue Growth Rate in Brucellosis Treatment Business (2018-2023)
Figure 51. ZeotisInc. Revenue Growth Rate in Brucellosis Treatment Business (2018-2023)
Figure 52. BoehringerIngelheim International GmbH. Revenue Growth Rate in Brucellosis Treatment Business (2018-2023)
Figure 53. Elanco Revenue Growth Rate in Brucellosis Treatment Business (2018-2023)
Figure 54. Virabc Inc. Revenue Growth Rate in Brucellosis Treatment Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 関節内出血治療の世界市場2023年：手術治療、医療治療
  • 四肢麻痺治療の世界市場2023年：経口、点滴、その他
  • セザリー症候群治療の世界市場2023年：放射線療法、化学療法、免疫療法、体外光化学療法
  • 膵臓がん転移治療の世界市場2023年：化学療法、標的療法、その他
  • 体部白癬治療の世界市場2023年：局所、経口
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA7434 )"ブルセラ症治療の世界市場2023年：経口式、注射式" (英文：Global Brucellosis Treatment Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。